Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · HEMO ORGANIC LIMITED · 9 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
HEMO ORGANIC LIMITED
BSE: 524590
BSE: 524590
Services › Services › Commercial Services & Supplies › Trading & Distributors
HEMO ORGANIC LIMITED
StateQ4 FY26 filed
Last close—
Market cap—
TTM P/E · P/B · EV/EBITDA— · — · —
HEMO ORGANIC LIMITED is a Commercial Services & Supplies company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · standalone | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 2 | 1 |
| EBITDA (ex other income) | (0) | (0) | (0) | (0) | (0) |
| margin % | (916.2) | (1137.5) | (1099.1) | (1.8) | (53.8) |
| Owners' profit | (0) | (0) | (0) | 0 | (1) |
| EPS, as reported (₹) | (0.18) | (0.16) | (0.76) | 0.47 | (2.24) |
| ROE % · ROCE % | (1835.3) · (162.2) | 106.6 · 341.3 | 83.7 · (26.6) | (108.2) · 1.9 | (585.5) · (17.3) |
| Debt / equity (x) | 10.29 | (0.69) | (3.92) | (33.74) | 32.37 |
| Cash from operations | (0) | 0 | (1) | (0) | (1) |
| Capex | 0 | 0 | 0 | 0 | (0) |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · HEMO ORGANIC LIMITED · 9 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 |
| Profit before tax | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (0) |
| Net profit | (0) | (0) | (0) | 0 | (0) | (0) | (0) | (1) |
| EPS (₹) | (0.01) | (0.23) | (0.37) | 1.08 | (0.25) | 0.09 | (0.45) | (1.46) |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| REDINGTON LIMITED | 30,351 | 17.8 | 2.91 | 14.1 | 12.3 | 15.7 | 15.9 | 2.2 |
| MMTC LIMITED | 8,166 | 18.3 | 3.85 | 17.4 | 18.3 | 21.6 | (83.7) | 18426.5 |
| MSTC LIMITED | 4,696 | 20.0 | 5.20 | 13.9 | 24.2 | 31.8 | (13.9) | 86.5 |
| CREATIVE NEWTECH LIMITED | 1,593 | 24.5 | 4.11 | 18.4 | 18.1 | 21.0 | — | 5.2 |
| Pervasive Commodities Limited | 1,178 | — | 13.10 | — | (0.0) | (0.0) | — | 45.0 |
| The Yamuna Syndicate Ltd | 755 | 8.3 | 0.59 | 190.1 | 4.0 | 0.3 | 4.8 | 6.2 |
| SHIV AUM STEELS LIMITED | 748 | 65.8 | 6.19 | 47.7 | 6.0 | 6.9 | — | 4.9 |
| SHANKARA BUILDPRO LIMITED | 609 | 4.6 | 1.12 | 2.7 | 23.4 | 31.8 | — | 3.3 |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| ROCE | (17.3) | 2.1 | 168 of 177 | 5% |
| ROE | (585.5) | 2.3 | 158 of 158 | 0% |
| Debt / Equity | 32.4 | 0.1 | 154 of 154 | 0% |
| EBITDA margin | (32.0) | 4.5 | 122 of 137 | 11% |
| Revenue growth | (61.6) | (8.6) | 99 of 135 | 27% |
| Profit growth | (235.4) | 0.6 | 137 of 157 | 13% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · HEMO ORGANIC LIMITED · 9 October 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 5 Oct 2026 · Qmin Realities acquires 24.76 percent stake in Hemo Organic via preferential allotment | ownership changes | medium | — | — |
| 5 Oct 2026 · Vacro Enterprises acquires 17 lakh shares of Hemo Organic via preferential allotment | ownership changes | medium | — | — |
| 3 Oct 2026 · Board okays about 9x authorised capital hike, alters objects, appoints CS | management changes | medium | — | — |
| 3 Oct 2026 · Hemo Organic board alters main objects, hikes authorised capital 9x | strategic transactions | medium | — | — |
| 28 Sept 2026 · Trading window closed from October 1, 2026 for Q2 results announcement | compliance | minimal | — | — |
| 21 Sept 2026 · Board meeting scheduled for 23 Sep 2026 cancelled due to unavoidable reasons | board shareholder meetings | low | — | — |
| 19 Sept 2026 · Company Secretary and Compliance Officer resigns | management changes | medium | — | — |
| 19 Sept 2026 · Company Secretary and Compliance Officer resigns due to personal reasons | management changes | medium | — | — |
| 19 Sept 2026 · Board meeting on 23 Sep 2026 to consider fund raising proposal | fund raising | high | — | — |
| 26 Jun 2026 · Trading window closed from July 1 for Q1 results declaration | compliance | minimal | — | — |
Source: exchange announcements; reaction = close-to-close from the filing's session.
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in